¿Cuáles son los mecanismos de acción de la inmunoterapia en oncología?

Article Sidebar

PDF (Spanish)

Main Article Content

Federico Cayol
Sección Oncología. Servicio de Clínica Médica Hospital Italiano de Buenos Aires

Downloads

##plugins.themes.bootstrap3.displayStats.noStats##
Published: 2018-09-30
DOI: https://doi.org/10.51987/Rev.Hosp.Ital.B.Aires.v38i3.570

Article Details

Issue

Vol. 38 No. 3 (2018): Revista del Hospital Italiano de Buenos Aires

Section

Ask the expert
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

How to Cite

1.
Cayol F. ¿Cuáles son los mecanismos de acción de la inmunoterapia en oncología? Rev Hosp Ital B.Aires [Internet]. 2018 Sep. 30 [cited 2026 Jul. 31];38(3):123-5. Available from: https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/570

References

Coley WB. The treatment of malignant tumors by repeated inoculations of erysipelas: with a report of ten original cases. Am J Med Sci. 1893; 105:487-511.

Finn OJ. Molecular Origins of Cancer Cancer Immunology. N Engl J Med 2008;358:2704-15.

Oiseth SJ, Aziz MS. Cancer immunotherapy: a brief review of the history, possibilities, and challenges ahead. J Cancer Metastasis Treat.2017; 3:250-6.

Puzanov I, Diab A, Abdallah K, et al. Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group. J Immunother Cancer. 2017; 5:95.

Shoushtari AN, Wolchok J, Hellman M. Principles of cancer immunotherapy. UptoDate 2018.